Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heart Failure NYHA Class IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT03631654
What this trial is testing

Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes

Who this might be right for
Heart Failure NYHA Class IV
University of Maryland, Baltimore
Not applicableWithdrawnNCT03947853
What this trial is testing

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

Who this might be right for
Heart FailureHeart Failure NYHA Class IIIHeart Failure NYHA Class II+1 more
Elpen Pharmaceutical Co. Inc.
Post-approval studies (Phase 4)Ended earlyNCT03026088
What this trial is testing

Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants

Who this might be right for
Heart Failure
Merck KGaA, Darmstadt, Germany 20
Not applicableStudy completedNCT01872949
What this trial is testing

C-Pulse® System European Multicenter Study

Who this might be right for
Heart Failure
Nuwellis, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00578695
What this trial is testing

THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation

Who this might be right for
Hyponatremia
CardioKine Inc. 652
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07064525
What this trial is testing

Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension

Who this might be right for
Hypertension (HTN)NYHA Class III Heart FailureNYHA Class IV Heart Failure+1 more
Shin Poong Pharmaceutical Co. Ltd. 252